...
机译:将miR-182和miR-150循环的作用作为埃及患者HCV感染后肝硬化和肝细胞癌的生物标志物
Department of Clinical &
Chemical Pathology Kasr Al-Ainy School of Medicine Cairo University;
Endemic Medicine Department Liver Unit Cairo University Center of Hepatic Fibrosis (CUC-HF);
Department of Clinical &
Chemical Pathology Kasr Al-Ainy School of Medicine Cairo University;
Department of Clinical &
Chemical Pathology Kasr Al-Ainy School of Medicine Cairo University;
Department of Clinical &
Chemical Pathology Kasr Al-Ainy School of Medicine Cairo University;
Department of Clinical &
Chemical Pathology Kasr Al-Ainy School of Medicine Cairo University;
Department of Clinical &
Chemical Pathology Kasr Al-Ainy School of Medicine Cairo University;
Endemic Medicine Department Liver Unit Cairo University Center of Hepatic Fibrosis (CUC-HF);
Endemic Medicine Department Liver Unit Cairo University Center of Hepatic Fibrosis (CUC-HF);
Department of Clinical &
Chemical Pathology Kasr Al-Ainy School of Medicine Cairo University;
Hepatocellular carcinoma; Hepatitis C; miR-182; miR-150; qRT-PCR;
机译:将miR-182和miR-150循环的作用作为埃及患者HCV感染后肝硬化和肝细胞癌的生物标志物
机译:血清生物标志物,用于早期检测埃及患者HCV感染的肝细胞癌
机译:循环miRNA-122,miRNA-199a和miRNA-16作为埃及慢性丙型肝炎病毒感染患者肝细胞癌早期检测的生物标志物
机译:TGF-β1基因单核苷酸多态性(SNP-Codon10)对HCV感染后埃及患者肝细胞癌风险的影响
机译:基线多伦多HCC风险指数(THRI)和白蛋白预测HCV感染持续病毒响应(SVR)后肝细胞癌(HCC)的低风险
机译:MicroRNA 196a和499多态性与埃及患者HCV感染后肝硬化和肝细胞癌的发展
机译:血清生物标志物,用于早期检测埃及患者HCV感染的肝细胞癌